Arvinas (ARVN) EPS (Basic) Growth (1y) (2018 - 2026)
Arvinas (ARVN) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 88.81% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,201.33% |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - | -178.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -178.71% |
| Dec 31, 2025 | -51.55% |
| Sep 30, 2025 | 29.73% |
| Jun 30, 2025 | -71.24% |
| Mar 31, 2025 | 218.13% |
| Dec 31, 2024 | 77.51% |
| Sep 30, 2024 | 42.23% |
| Jun 30, 2024 | 59.96% |
| Mar 31, 2024 | 36.15% |
| Dec 31, 2023 | -85.25% |
| Sep 30, 2023 | 0.73% |
| Jun 30, 2023 | 3.62% |
| Mar 31, 2023 | -31.50% |
| Dec 31, 2022 | -63.30% |
| Sep 30, 2022 | -26.63% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -36.71% |
| Dec 31, 2021 | 7.89% |
| Sep 30, 2021 | -9.94% |
| Jun 30, 2021 | -41.40% |